Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Simultaneous diagnosis and treatment of cancer now possible
Cancer is not incurable anymore. Nevertheless, according to statistics released by Statistics Korea last year,…
Sox9 protein enables molecular time travel that can lead to colorectal cancer
Normally the lining of the colon forms a series of steep hills and valleys. At…
Scientists create mouse avatars to treat multiple myeloma
An international group of researchers, led by Dr José Ángel Martínez-Climent at the Cima University of…
Cancer screening rates decline when patients see doctors later in day
Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.